Trimedyne, Inc. is a medical technology company focused on developing and manufacturing advanced fluid management and vascular access products. Headquartered in Holliston, Massachusetts, Trimedyne’s portfolio includes needle-free connectors, syringe infusion pumps, IV administration sets and safety-engineered blood collection devices. These offerings are designed to enhance patient safety by minimizing the risk of healthcare-associated infections and improving the reliability of intravenous therapies.
Since its incorporation in 2009, Trimedyne has invested in research and development to bring innovative solutions to the hospital, outpatient and home healthcare markets. Its proprietary needleless connector platform helps reduce catheter-related bloodstream infections, while its line of safety syringes and blood collection products addresses sharps injury prevention. The company’s products hold various regulatory clearances and are used in clinical settings worldwide.
Trimedyne serves a diverse customer base that includes hospitals, clinics, long-term care facilities and pharmaceutical manufacturers across North America, Europe and select international markets. By maintaining strategic partnerships with key distributors and carefully managing its global supply chain, the company ensures timely delivery of critical medical supplies to healthcare professionals and patients.
Led by President and Chief Executive Officer William W. Gunther III, Trimedyne’s management team brings decades of experience in medical device innovation, quality assurance and commercial operations. The company continues to expand its product pipeline through internal development and targeted acquisitions, with a commitment to advancing safety and efficiency in vascular access and infusion therapy.
AI Generated. May Contain Errors.
